23 September 2020
Clifford Chance advises Permira on the acquisition of Neuraxpharm
Advising firms
Deal team
30 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Anselm Raddatz | Clifford Chance | Partner | Corporate/Private Equity | Frankfurt |
| Jörg Rhiel | Clifford Chance | Partner | Corporate/Private Equity | Frankfurt |
| Peter Dieners | Clifford Chance | Partner | Corporate/Healthcare | Düsseldorf |
| Maria-Franziska Röntsch | Clifford Chance | Senior associate | Corporate/Private Equity | Frankfurt |
| Nico Basener | Clifford Chance | Senior associate | Corporate/Private Equity | Frankfurt |
| Carolin Kemmner | Clifford Chance | Senior associate | Corporate/Healthcare | Düsseldorf |
| Ann-Cathrin Bergstedt | Clifford Chance | Associate | Corporate/Healthcare | Düsseldorf |
| Ulrich Lembeck | Clifford Chance | Of counsel | Corporate/Healthcare | Düsseldorf |
| Daniel Gutmann | Clifford Chance | Associate | Corporate/Private Equity | Frankfurt |
| Friedrich von Bülow | Clifford Chance | Associate | Corporate/Private Equity | Frankfurt |
| Gerd Hegele | Clifford Chance | Senior associate | Corporate/Private Equity | Frankfurt |
| Marie-Christine Schulte | Clifford Chance | Associate | Corporate/Private Equity | Düsseldorf |
| Matthias Christian Forster | Clifford Chance | Associate | Corporate/Private Equity | Düsseldorf |
| Michael Kümmel | Clifford Chance | Associate | Corporate/Private Equity | Munich |
| Marc Besen | Clifford Chance | Partner | Competition | Düsseldorf |
| Dimitri Slobodenjuk | Clifford Chance | Counsel | Competition | Düsseldorf |
| Caroline Scholke | Clifford Chance | Senior associate | Competition | Düsseldorf |
| Anna Maurer | Clifford Chance | Associate | Competition | Düsseldorf |
| Florian Reiling | Clifford Chance | Counsel | IP | Düsseldorf |
| Stefan Simon | Clifford Chance | Partner | Employment | Frankfurt |
| Christopher Fischer | Clifford Chance | Counsel | Employment | Frankfurt |
| Spencer Baylin | Clifford Chance | Partner | Corporate/Private Equity | London |
| Martin Kolmar | Clifford Chance | Other | Corporate/Private Equity | London |
| Victoria Ho | Clifford Chance | Senior associate | Corporate/Private Equity | London |
| Samir Azzouzi Maanan | Clifford Chance | Partner | Not stated | Madrid |
| Guillermo Guardia | Clifford Chance | Partner | Not stated | Barcelona |
| Carme Briera Dalmau | Clifford Chance | Counsel | Not stated | Not stated |
| Sonia Sebe Marin | Clifford Chance | Associate | Not stated | Not stated |
| Jorge Daniel Garcia Juarez | Clifford Chance | Associate | Not stated | Not stated |
| Patricia Puertas Diaz | Clifford Chance | Associate | Not stated | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- PermiraBuy-side
- Counterparties
- Neuraxpharm (Target)
Apax Partners (Sell-side)